CATAG



AUGUST 2013 Summary of Changes to the Queensland Health List of Approved Medicines (LAM)as recommended by the Queensland Health Medicines Advisory Committee (QHMAC)ITEM #MEDICINEDECISION & DATE EFFECTIVERESTRICTION13/071IPILIMUMAB INJECTION 360mg (maximum amount)ADDED01-Aug-13Specialist Staff for use as per the Efficient Funding of Chemotherapy – Section 100 Arrangements Supplement of the PBS (Refer to .au)13/070OMEPRAZOLE MAGNESIUM TABLET 10mgADDED01-Oct-13Specialist Staff and Country Medical Superintendents for oral administration in children under 1 year of age. (Tablets do not disperse evenly; not suitable for use in 6Fr NG tube - use omeprazole suspension)13/069PNEUMOCOCCAL CONJUGATE VACCINE (13-VALENT) INJECTION, Pre-filled syringe 0.5mL (Prevenar 13?) ADDED01-Oct-13Adults at increased risk of invasive pneumococcal infection due to functional or anatomical asplenia.[Note: This item was discussed again at the September 2013 QHMAC meeting and further changes to its restriction were recommended. Refer to the September 2013 Summary of Changes, when available, for the revised LAM restriction].13/083RALTEGRAVIR Tablet 25mg, 100mgADDED 01-Sep-13 (to be reflected in 1 Oct LAM)Specialist Staff for use in accord with Highly Specialised Drugs Program indications13/048SODIUM CHLORIDE COMPOUND (Ringers lactate with glucose) Powder for reconstitution – sachet (4) plus bottle with paediatric tip (FLO kids Sinus Care Starter Kit?)ADDED 01-Oct-13For initial supply post ENT surgery and sinus irrigation for children with chronic rhinosinusitis which may co-exist with cystic fibrosis and asthma.13/051VITAMIN, FAT SOLUBLE COMPOUND IN TOCOPHEROL PEG SUSPENSION chewable tablet (60), soft gel capsule (60), paediatric liquid 60mL (AquADEKs)ADDED 01-Oct-13Paediatricians, in consultation with RCH’s Paediatric Gastroenterology and Hepatology Service or Cystic Fibrosis Clinic, for infants and children with cholestasis (biliary atresia, alagilles, cystic fibrosis) and FSV deficiency resistant to standard oral FSV supplements. (Children should have documented deficiency of Vit K [abnormal Prothrombin time correctable with Vit K IMI], A, D and E on blood testing.) Where an item is not TGA approved, patients should be made fully aware of its status and appropriate consent obtained”.13/073AAMISULPRIDE ORAL LIQUID 100 mg per mL, TABLET 100mg, 200mg, 400mgAMENDED01-Oct-13For use as per the PBS indications following failure of risperidone or olanzapine 13/076APIXABAN Tablet 2.5mgAMENDED01-Sep-13(to be reflected in 1 Oct LAM)For orthopaedic prophylaxis of venous thromboembolism in total hip and knee replacement13/073BARIPIPRAZOLE TABLET 5mg, 10mg, 15mg, 20mg, 30mgAMENDED01-Oct-13For use as per the PBS indications following failure of risperidone or olanzapine 13/073CASENAPINE WAFER 5mg, 10mgAMENDED01-Oct-13For use as per the PBS indications following failure of risperidone or olanzapine 13/073DOLANZAPINE TABLET 2.5mg, 5mg, 7.5mg, 10mg; WAFER 5mg, 10mg, 20mg AMENDED01-Oct-13For use as per the PBS indications13/070AOMEPRAZOLE MAGNESIUM TABLET 20mgAMENDED01-Oct-13Specialist Staff and Country Medical Superintendents for oral administration in children under 1 year of age. (Tablets do not disperse evenly; not suitable for use in 6Fr NG tube - use omeprazole suspension)13/073EQUETIAPINE IMMEDIATE RELEASE TABLET 25mg, 100mg; MODIFIED RELEASE TABLET 50mg, 200mg, 300mg, 400mgAMENDED01-Oct-13For use as per the PBS indications following failure of risperidone or olanzapine 13/073FRISPERIDONE TABLET and ORALLY DISINTEGRATING TABLET 0.5mg, 1mg, 2mg, 3mg, 4mg; ORAL LIQUID 1mg per mL, 100mLAMENDED01-Oct-13For use as per the PBS indications13/063EVITAMIN COMPOUND WITH MINERALS, CHEWABLE TABLET (Centrum Kids? Chewable Tablets)AMENDED01-Oct-13Patients unable to swallow tablets13/073GZIPRASIDONE CAPSULE 20mg, 40mg, 60mg, 80mgAMENDED01-Oct-13For use as per the PBS indications following failure of risperidone or olanzapine13/028CINACALCET TABLET 30mg, 60mg, 90mgDEFERRED13/066LACTOBACILLUS ACIDOPHILUS & bifidobacterium bifidum CAPSULE 250mgDEFERRED13/074SEVOFLURANE INHALATION ANAESTHETIC 250mLDEFERRED13/063AALPROSTADIL INJECTION 5microgram in 1mLDELETED01-Oct-1313/063CBISACODYL - MAGNESIUM CITRATE (Pack containing 3 x 5mg bisacodyl tablets plus 1 x 10mg bisacodyl suppository and 1 x sachet magnesium citrate effervescent [equiv to 3g magnesium oxide (Go Kit Plus?)DELETED01-Oct-1313/063BBISACODYL PAEDIATRIC SUPPOSITORIES 5mg (6)DELETED01-Oct-1313/063DSODIUM HYALURONATE Intraocular Solution for Injection 10mg per mL, 1mLDELETED01-Oct-1313/075PALIVIZUMAB POWDER FOR INJECTION 50mg, 100mgNOT ADDED13/067RISEDRONATE SODIUM TABLET ENTERIC COATED 35mg NOT ADDED13/049SODIUM CHLORIDE COMPOUND (Sodium chloride, sodium bicarbonate, potassium chloride, calcium, magnesium chloride hexahydrate) Nasal Spray 15mL (FLO Baby Saline + Nasal Spray)NOT ADDED13/068GABAPENTIN TABLET 300mgNOT AMENDED7.COUNCIL OF AUSTRALIAN THERAPEUTIC ADVISORY GROUPS (CATAG) UPDATENOTED13/072CYCLOPHOSPHAMIDE Tablet 50mgNOTED13/065FOR INFORMATION - HYDROXYETHYL STARCH Solutions for infusionNOTED13/019MAGNESIUM SULFATE in water for Injection, prefilled syringe (PFS) 4g in 20mL (20%), and 10g in 50mL (20%)NOTED12/T09SOA – LOW MOLECULAR WEIGHT HEPARINS (LMWHs)NOTED ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download